Results for: cancer screening

The Cancer Moonshot: Hype versus reality

The Cancer Moonshot has been promoted as a strategy to break the logjam that seems to be holding up new, much more effective treatments for cancer. The key word is "seems," because in reality the Cancer Moonshot is more hype than promise.

/ September 12, 2016

Newborn Phototherapy and Cancer: Cutting Edge Research or “Big Data” Failure?

While social media and news outlets were reacting, or in some cases overreacting, to a new rodent-based medical study on the unlikely link between cell phone use and brain cancer last month, two studies and an accompanying commentary were quietly published in Pediatrics that raised similar concerns. Rather than cell phone use, the proposed potential cause of pediatric cancer in these newly...

/ June 3, 2016

Reclassifying thyroid cancer and the willful misunderstanding of overdiagnosis

If there’s one lesson that we here at Science-Based Medicine like to emphasize, it’s that practicing medicine and surgery is complicated. Part of the reason that it’s complicated is that for many diseases our understanding is incomplete, meaning that physicians have to apply existing science to their treatment as well as they can. The biology of cancer, in particular, can be vexing....

/ April 25, 2016

Confusing overdiagnosis for an “epidemic” of thyroid cancer in Japan after Fukushima

One of my favorite topics to blog about for SBM is the topic of overdiagnosis and overtreatment. These are two interrelated phenomena that most people are blissfully unaware of. Unfortunately, I’d also say that the majority of physicians are only marginally more aware than the public about these confounders of screening programs, if even that. Overdiagnosis has long been appreciated to be...

/ March 14, 2016

The American Cancer Society’s new mammography guidelines: Déjà vu all over again

One of the things that feels the weirdest about having done the same job, having been in the same specialty, for a longer and longer time is that you frequently feel, as the late, great Yogi Berra would have put it, déjà vu all over again. This is particularly true in science and medicine, where the same issues come up again and...

/ October 21, 2015

Presidential candidate Ben Carson: Shilling for Mannatech with his very own alternative cancer cure testimonial?

Over the years, mainly at my not-so-super-secret other blog, I’ve frequently made the points that the vast majority of physicians are not scientists and, in fact, that many of them suffer from a severe case of Dunning-Kruger when it comes to science outside of biomedical sciences—or even biomedical sciences outside of their medical field of expertise. The most common science I’ve seen...

/ October 11, 2015

An aspirin a day to prevent heart attacks, strokes, and cancer?

Taking an aspirin a day has always been controversial when it comes to preventing disease before it occurs. Now a task force is recommending daily use under some circumstances. Do the benefits really outweigh the risks?

/ September 24, 2015

Cancer Centers and Advertising Practices

You have probably seen the TV commercials or other ads for Cancer Treatment Centers of America. They make it sound like “the place to go” if you have cancer. They claim to be “different,” to combine the best cancer technologies with natural therapies in a humane, patient-centered approach that helps you fight the disease and maintain your quality of life. They offer...

/ April 14, 2015

Angelina Jolie, surgical strategies for cancer prevention, and genetics denialism (revisited)

Sometimes, weird things happen when I’m at meetings. For example, I just got home from the Society of Surgical Oncology (SSO) meeting in Houston over the weekend. Now, one thing I like about this meeting is that, unlike so many other meetings these days—cough, cough, ASCO, I’m looking at you—at the SSO there wasn’t a single talk I could find about “complementary...

/ March 30, 2015

Screening for disease in people without symptoms: The reality

One of the most contentious questions that come up in science-based medicine that we discuss on this blog is the issue of screening asymptomatic individuals for disease. The most common conditions screened for that we, at least, have discussed on this blog are cancers (e.g., mammography for breast cancer, prostate-specific antigen screening for prostate cancer, ultrasound screening for thyroid cancer), but screening...

/ February 2, 2015